To unravel other therapy-induced changes or compensatory mechanisms that could be a reason for the only slightly decreased tumor vascularization, further qRT-PCR analyses were conducted, with a focus on classic proangiogenic molecules, such as Vegf with its receptors Vegfr1 and Vegfr2 as well as Cxcr1. The gene discussed is KDR; the disease is neoplasm.